Of note, these pathways are commonly activated in lung cancer, which in turn can lead to increased SLC7A11 expression through diverse mechanisms, including transcriptional activation or increased mRNA stability [28,36]. This evidence concerns the gene SLC7A11 and lung carcinoma.